![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/cadrenal-therapeutics-to-present-at-the-emerging-growth-conference-on-june-12-2024-302169889.html
https://www.prnewswire.com/news-releases/cadrenal-therapeutics-highlights-presentation-of-new-trial-data-at-ishlt-conference-demonstrating-the-importance-of-anticoagulation-quality-in-lvad-patients-302161345.html
https://www.prnewswire.com/news-releases/cadrenal-therapeutics-to-participate-in-the-lytham-partners-spring-2024-investor-conference-on-may-30-2024-302153439.html
https://www.prnewswire.com/news-releases/cadrenal-therapeutics-to-participate-in-noble-capital-markets-emerging-growth-virtual-healthcare-equity-conference-on-april-18-2024-302114776.html
https://www.prnewswire.com/news-releases/cadrenal-therapeutics-provides-fourth-quarter-2023-corporate-update-302084864.html
https://www.prnewswire.com/news-releases/cadrenal-therapeutics-to-participate-at-technology-and-heart-failure-therapeutics-tht-conference-302070595.html
https://www.prnewswire.com/news-releases/cadrenal-therapeutics-appoints-jeff-cole-as-chief-operating-officer-in-advance-of-tecarfarin-phase-3-pivotal-trial-302057004.html
https://www.prnewswire.com/news-releases/cadrenal-therapeutics-to-present-at-the-biotech-showcase-on-january-8-2024-alongside-the-jp-morgan-annual-healthcare-conference-302025890.html
https://www.prnewswire.com/news-releases/noble-capital-markets-initiates-coverage-on-cadrenal-therapeutics-with-outperform-rating-and-us4-00-price-target-302018426.html
https://www.prnewswire.com/news-releases/cadrenal-therapeutics-engages-the-sage-group-to-advance-tecarfarins-late-stage-development-and-commercialization-302012016.html